retatrutide drug Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Weight loss drug retatrutide use

For patients using GLP-1 medications or considering future therapies like retatrutide, the goal should be fat loss with lean-mass protection

Headaches may recur briefly after dose increases but typically resolve with continued use and supportive measures like adequate hydration

From $149/mo Wegovy pill self-pay Providers 5 Reviewed in 2026 Covered 67% of employer plans We may earn a commission when you click links to providers

Yes, if you meet NICE eligibility criteria, typically when triple oral therapy for type 2 diabetes is inadequate and specific BMI or comorbidity thresholds apply

Below is a comprehensive timeline based on published data from the STEP trials for semaglutide, the SURMOUNT trials for tirzepatide, and thousands of documented patient experiences

These encouraging results highlight the potential benefits of LC supplementation as a therapeutic intervention in managing sepsis and offer promising prospects for enhancing patient outcomes in critical care settings